CORE-IGF-LR3 is a modified analog of insulin-like growth factor-1 (IGF-1) designed for laboratory investigation of IGF-1 receptor signaling and associated intracellular pathways.
IGF-1 LR3 incorporates structural modifications relative to native IGF-1 that influence its biochemical behavior and interaction with IGF-associated binding systems.
Its research profile makes CORE-IGF-LR3 relevant to controlled studies involving:
CORE-IGF-LR3 supplied by Core Aminos Research is intended exclusively for laboratory research, analytical testing, and scientific investigation.
For Research Use Only. Not for human or animal use.
IGF-1 LR3 is a structurally modified form of IGF-1 containing an Arg substitution and an extended amino-acid sequence relative to native IGF-1.
These modifications make the compound useful in laboratory studies examining:
The IGF-1 receptor is a receptor tyrosine kinase involved in numerous intracellular signaling networks.
CORE-IGF-LR3 may be used to investigate:
IGF-1 receptor activation is closely associated with PI3K/Akt signaling.
Research applications may examine:
These studies are intended to characterize molecular signaling mechanisms under controlled experimental conditions.
CORE-IGF-LR3 may also be incorporated into experimental systems examining MAPK-associated pathways.
Potential research endpoints include:
IGF-associated signaling is frequently investigated in cell proliferation research.
CORE-IGF-LR3 may be relevant to:
CORE-IGF-LR3 may be used in controlled experimental models examining differentiation-associated signaling.
Research may include:
IGF-1 receptor pathways interact with intracellular systems associated with protein synthesis and cellular growth signaling.
Potential laboratory investigations include:
These applications refer specifically to cellular and biochemical models rather than physiological or performance outcomes.
Modified IGF analogs may differ from native IGF-1 in their interaction with IGF-binding proteins.
CORE-IGF-LR3 may therefore be useful for research involving:
CORE-IGF-LR3 may be incorporated into comparative studies involving:
Such studies may help characterize differences in receptor activation and downstream signaling behavior.
CORE-IGF-LR3 may be relevant to:
Experimental concentrations, controls, methodologies, and endpoints should be determined by qualified research personnel according to the specific laboratory model.
Product Name: CORE-IGF-LR3
Compound: IGF-1 LR3
Compound Type: Modified IGF-1 Research Peptide
Primary Research Target: IGF-1 Receptor
Research Category: Cellular & Receptor Signaling Research
Primary Research Focus: IGF-1R signaling, PI3K/Akt, MAPK pathways, cellular proliferation and differentiation
Purity: Refer to batch-specific Certificate of Analysis
Intended Use: Laboratory research and analytical applications only
Batch-specific identity, purity, and analytical specifications should be verified using the applicable Certificate of Analysis.
CORE-IGF-LR3 may be evaluated using appropriate analytical methodologies including:
Refer to the corresponding batch Certificate of Analysis for applicable analytical data.
CORE-IGF-LR3 should be maintained according to the storage conditions specified on the product label and associated batch documentation.
General laboratory handling considerations include:
CORE-IGF-LR3 is a modified IGF-1 analog intended for laboratory investigation of receptor-mediated cellular signaling.
Its research profile makes it relevant to studies involving:
CORE-IGF-LR3 is supplied exclusively as a laboratory research material.
CORE-IGF-LR3 is intended strictly for laboratory research and analytical investigation.
Not for human consumption.
Not for injection or personal use.
Not for animal use.
Not for athletic, performance-enhancement, medical, diagnostic, therapeutic, or veterinary applications.
Not intended to diagnose, treat, cure, or prevent any disease or health condition.
Core Aminos Research supplies CORE-IGF-LR3 exclusively for qualified laboratory and scientific research applications.